Children with prenatal opioid exposure face struggles in health, education, and social well-being throughout their childhoods and teenage years, even when sociodemographic factors are factored out. The global opioid crisis has largely been viewed as a crisis of adult users, but it has also led to a rise in children exposed to opioids before birth, only some of whom are diagnosed with neonatal abstinence syndrome—essentially, withdrawal. In 2023, approximately 95,000 American infants may have been exposed to opioids in utero. Gaëlle Simard-Duplain and Jonathan Zhang analyzed two decades of linked administrative data in British Columbia for 897,668 births that allow association of prenatal opioid exposure with healthcare utilization, educational outcomes, special education services, interactions with child protective services, and government welfare usage.
Children with prenatal opioid exposure incur more healthcare expenditures through age 18 than those without prenatal opioid exposure. Exposed children are also more likely to receive an inclusive education designation, particularly for physical disabilities and chronic impairments, and to perform worse in school than their unexposed peers. According to the authors, prenatal screening, targeted interventions, and integrated policymaking are needed to break the intergenerational cycle of opioid-related harm.
